Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare clearinghouse processing 15B+ annual claims acquired by Optum; 2024 ransomware attack caused $1B+ provider disruption and sparked nationwide healthcare cybersecurity overhaul.
Change Healthcare (now part of Optum) is a healthcare technology company providing claims processing, payment management, network intelligence, and clinical decision support tools to the US healthcare ecosystem — connecting payers, providers, pharmacies, and patients through data and technology infrastructure. Change Healthcare was acquired by UnitedHealth Group's Optum subsidiary in October 2022 following a lengthy regulatory review that included a DOJ lawsuit to block the acquisition on antitrust grounds.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.